Skip to main content Accessibility help
×
Home
  • Print publication year: 2015
  • Online publication date: March 2015

Chapter 37 - The vulva and vagina

References

1. Wilkinson EJ, Hardt NS. Vulva. In Sternberg SS, ed. Histology for Pathologists, 2nd edn. Philadelphia, PA: Lippincot-Raven; 1997: pp. 851–866.
2. Van der Putte SC, Van Gorp LH. Cysts of mammarylike glands in the vulva. Int J Gynecol Pathol 1995; 14(2): 184–188.
3. Iversen T, Aas M. Lymph drainage from the vulva. Gynecol Oncol 1983; 16(2): 179–189.
4. Wilkinson EJ. Protocol for the examination of specimens from patients with carcinomas and malignant melanomas of the vulva: a basis for checklists. Cancer Committee of the American College of Pathologists. Arch Pathol Lab Med 2000; 124(1): 51–65.
5. Chan JK, Sugiyama V, Pham H, et al. Margin distance and other clinico-pathologic prognostic factors in vulvar carcinoma: a multivariate analysis. Gynecol Oncol 2007; 104(3): 636–641.
6. Groenen SMA, Timmers PJ, Burger CW. Recurrence rate in vulvar carcinoma in relation to pathological margin distance. Int J Gynecol Cancer 2010; 20(5): 869–873.
7. Dewhurst CJ. Congenital malformations of the genital tract in childhood. J Obstet Gynaecol Br Commonw 1968; 75(4): 377–391.
8. Verkauf BS, Von Thron J, O’Brien WF. Clitoral size in normal women. Obstet Gynecol 1992; 80(1): 41–44.
9. Morrone A, Hercogova J, Lotti T. Stop female genital mutilation: appeal to the international dermatologic community. Int J Dermatol 2002; 41(5): 253–263.
11. Hammerschlag MR. Sexually transmitted diseases in sexually abused children: medical and legal implications. Sex Transm Infect 1998; 74(3): 167–174.
12. Derksen DJ. Children with condylomata acuminata. J Fam Pract 1992; 34(4): 419–423.
13. Obalek S, Misiewicz J, Jablonska S, et al. Childhood condyloma acuminatum: association with genital and cutaneous human papillomaviruses. Pediatr Dermatol 1993; 10(2): 101–106.
14. Mittal K, Palazzo J. Cervical condylomas show higher proliferation than do inflamed or metaplastic cervical squamous epithelium. Mod Pathol 1998; 11(8): 780–783.
15. Ferenczy A, Mitao M, Nagai N, et al. Latent papillomavirus and recurring genital warts. N Engl J Med 1985; 313(13): 784–788.
16. Maccato ML, Kaufman RH. Herpes genitalis. Dermatol Clin 1992; 10(2): 415–422.
17. Cokic-Damjanovic J, Horvat E, Balog A. [Herpes simplex virus and malignancies of female genital organs]. Med Pregl 2001; 54(9–10): 432–437.
18. Koutsky LA, Stevens CE, Holmes KK, et al. Underdiagnosis of genital herpes by current clinical and viral-isolation procedures. N Engl J Med 1992; 326(23): 1533–1539.
19. LaGuardia KD, White MH, Saigo PE, et al. Genital ulcer disease in women infected with human immunodeficiency virus. Am J Obstet Gynecol 1995; 172(2 Pt 1): 553–562.
20. Chen CY, Ballard RC, Beck-Sague CM, et al. Human immunodeficiency virus infection and genital ulcer disease in South Africa: the herpetic connection. Sex Transm Dis 2000; 27(1): 21–29.
21. Portnoy J, Ahronheim GA, Ghibu F, et al. Recovery of Epstein–Barr virus from genital ulcers. N Engl J Med 1984; 311(15): 966–968.
22. Rosen T, Tschen JA, Ramsdell W, et al. Granuloma inguinale. J Am Acad Dermatol 1984; 11(3): 433–437.
23. Mabey D, Peeling RW. Lymphogranuloma venereum. Sex Transm Infect 2002; 78(2): 90–92.
24. Jemec GB, Thomsen BM, Hansen U. The homogeneity of hidradenitis suppurativa lesions. A histological study of intra-individual variation. APMIS 1997; 105(5): 378–383.
25. Tham SN, Choong HL. Primary tuberculous chancre in a renal transplant patient. J Am Acad Dermatol 1992; 26(2 Pt 2): 342–344.
26. Lynch PJ, Moyal-Barracco M, Bogliatto F, et al. 2006 ISSVD classification of vulvar dermatoses: pathologic subsets and their clinical correlates. J Reprod Med 2007; 52(1): 3–9.
27. Lynch PJ, Moyal-Barracco M, Scurry J, et al. 2001 ISSVD terminology and classification of vulvar dermatological disorders: an approach to clinical diagnosis. J Low Genit Tract Dis 2001; 16(4): 339–344.
28. Macleod RI, Soames JV. Lichen sclerosus et atrophicus of the oral mucosa. Br J Oral Maxillofac Surg 1991; 29(1): 64–65.
29. Berth-Jones J, Graham-Brown RA, Burns DA. Lichen sclerosus et atrophicus – a review of 15 cases in young girls. Clin Exp Dermatol 1991; 16(1): 14–17.
30. Friedrich EG Jr. Lichen sclerosus. J Reprod Med 1976; 17(3): 147–154.
31. Powell J, Wojnarowska F. Childhood vulvar lichen sclerosus: an increasingly common problem. J Am Acad Dermatol 2001; 44(5): 803–806.
32. Degreef HJ, DeDoncker PR. Current therapy of dermatophytosis. J Am Acad Dermatol 1994; 31(3 Pt 2): S25–30.
33. Regauer S, Liegl B, Reich O, et al. Vasculitis in lichen sclerosus: an under recognized feature? Histopathology 2004; 45(3): 237–244.
34. Thomas RH, Ridley CM, McGibbon DH, et al. Anogenital lichen sclerosus in women. J R Soc Med 1996; 89(12): 694–698.
35. Neill SM, Lewis FM, Tatnall FM, et al. British Association of Dermatologists’ guidelines for the management of lichen sclerosus 2010. Br J Dermatol 2010; 163(4): 672–682.
36. Marren P, Walkden V, Mallon E, et al. Vulval cicatricial pemphigoid may mimic lichen sclerosus. Br J Dermatol 1996; 134(3): 522–524.
37. Urano S. Localized bullous pemphigoid of the vulva. J Dermatol 1996; 23(8): 580–582.
38. Farrell AM, Kirtschig G, Dalziel KL, et al. Childhood vulval pemphigoid: a clinical and immunopathological study of five patients. Br J Dermatol 1999; 140(2): 308–312.
39. Pelisse M. The vulvo-vaginal–gingival syndrome. A new form of erosive lichen planus. Int J Dermatol 1989; 28(6): 381–384.
40. Lewis FM. Vulval lichen planus. Br J Dermatol 1998; 138(4): 569–575.
41. Lewis FM, Harrington CI. Squamous cell carcinoma arising in vulval lichen planus. Br J Dermatol 1994; 131(5): 703–705.
42. Mullins DL, Wilkinson EJ. Pathology of the vulva and vagina. Curr Opin Obstet Gynecol 1994; 6(4): 351–358.
43. Chorzelski TP, Kudejko J, Jablonska S. Is papular acantholytic dyskeratosis of the vulva a new entity? Am J Dermatopathol 1984; 6(6): 557–560.
44. Lee SH, Jang JG. Papular acantholytic dyskeratosis of the genitalia. J Dermatol 1989; 16(4): 312–314.
45. Goldstein AT, Christopher K, Burrows LJ. Plasma cell vulvitis: a rare cause of intractable vulvar pruritus. Arch Dermatol 2005; 141(6): 789–790.
46. Pyka RE, Wilkinson EJ, Friedrich EG Jr, et al. The histopathology of vulvar vestibulitis syndrome. Int J Gynecol Pathol 1988; 7(3): 249–257.
47. Morin C, Bouchard C, Brisson J, et al. Human papillomaviruses and vulvar vestibulitis. Obstet Gynecol 2000; 95(5): 683–687.
48. Gerber S, Bongiovanni AM, Ledger WJ, et al. Defective regulation of the proinflammatory immune response in women with vulvar vestibulitis syndrome. Am J Obstet Gynecol 2002; 186(4): 696–700.
49. Hackel H, Hartmann AA, Burg G. Vulvitis granulomatosa and anoperineitis granulomatosa. Dermatologica 1991; 182(2): 128–131.
50. Foo W-C, Papalas JA, Robboy SJ, et al. Vulvar manifestations of Crohn’s disease. Am J Dermatopathol 2011; 33(6): 588–593.
51. Venkatesan A. Pigmented lesions of the vulva. Dermatol Clin 2010; 28(4): 795–805.
52. Edwards L. Pigmented vulvar lesions. Dermatol Ther 23(5): 449–457.
53. Gleason BC, Hirsch MS, Nucci MR, et al. Atypical genital nevi. A clinicopathologic analysis of 56 cases. Am J Surg Pathol 2008; 32(1): 51–57.
54. Clark WH Jr, Tucker MA. Problems with lesions related to the development of malignant melanoma: common nevi, dysplastic nevi, malignant melanoma in situ, and radial growth phase malignant melanoma. Hum Pathol 1998; 29(1): 8–14.
55. Carlson JA, Mu XC, Slominski A, et al. Melanocytic proliferations associated with lichen sclerosus. Arch Dermatol 2002; 138(1): 77–87.
56. Koenig C, Tavassoli FA. Nodular hyperplasia, adenoma, and adenomyoma of Bartholin’s gland. Int J Gynecol Pathol 1998; 17(4): 289–294.
57. Van der Putte SC. Mammary-like glands of the vulva and their disorders. Int J Gynecol Pathol 1994; 13(2): 150–160.
58. Pelosi G, Martignoni G, Bonetti F. Intraductal carcinoma of mammary-type apocrine epithelium arising within a papillary hydradenoma of the vulva. Report of a case and review of the literature. Arch Pathol Lab Med 1991; 115(12): 1249–1254.
59. Papiez JS, Hassenein A, Wilkinson E, et al. Recurrent atypical myxoid fibroepithelial polyp associated with vulvar Crohn’s disease. Int J Gynecol Pathol 2001; 20(3): 271–276.
60. Marquette GP, Su B, Woodruff JD. Introital adenosis associated with Stevens–Johnson syndrome. Obstet Gynecol 1985; 66(1): 143–145.
61. Kucera PR, Glazer J. Hydrocele of the canal of Nuck. A report of four cases. J Reprod Med 1985; 30(5): 439–442.
62. Fletcher CD, Tsang WY, Fisher C, et al. Angiomyofibroblastoma of the vulva. A benign neoplasm distinct from aggressive angiomyxoma. Am J Surg Pathol 1992; 16(4): 373–382.
63. Nielsen GP, Rosenberg AE, Young RH, et al. Angiomyofibroblastoma of the vulva and vagina. Mod Pathol 1996; 9(3): 284–291.
64. Tavassoli FA, Norris HJ. Smooth muscle tumors of the vulva. Obstet Gynecol 1979; 53(2): 213–217.
65. Nucci MR, Fletcher CD. Vulvovaginal soft tissue tumours: update and review. Histopathology 2000; 36(2): 97–108.
66. Nielsen GP, Young RH. Fibromatosis of soft tissue type involving the female genital tract: a report of two cases. Int J Gynecol Pathol 1997; 16(4): 383–386.
67. Nielsen GP, Rosenberg AE, Koerner FC, et al. Smooth-muscle tumors of the vulva. A clinicopathological study of 25 cases and review of the literature. Am J Surg Pathol 1996; 20(7): 779–793.
68. Van Glabeke E, Audry G, Hervet F, et al. Lipoma of the preputium clitoridis in neonate: an exceptional abnormality different from ambiguous genitalia. Pediatr Surg Int 1999; 15(2): 147–148.
69. Reis-Filho JS, Milanezi F, Soares MF, et al. Intradermal spindle cell/pleomorphic lipoma of the vulva: case report and review of the literature. J Cutan Pathol 2002; 29(1): 59–62.
70. O’Neal MF, Amparo EG. MR demonstration of extensive pelvic involvement in vulvar hemangiomas. J Comput Assist Tomogr 1988; 12(2): 219–221.
71. Geramizadeh B, Anbardar M-H, Shakeri S. Clitoromegaly caused by cavernous hemangioma: a rare case report and review of the literature. Urol Ann 2012; 4(3): 175–177.
72. Blair C. Angiokeratoma of the vulva. Br J Dermatol 1970; 83(3): 409–411.
73. Imperial R, Helwig EB. Angiokeratoma of the vulva. Obstet Gynecol 1967; 29(3): 307–312.
74. Cockerell CJ, LeBoit PE. Bacillary angiomatosis: a newly characterized, pseudoneoplastic, infectious, cutaneous vascular disorder. J Am Acad Dermatol 1990; 22(3): 501–512.
75. Reed JA, Brigati DJ, Flynn SD, et al. Immunocytochemical identification of Rochalimaea henselae in bacillary (epithelioid) angiomatosis, parenchymal bacillary peliosis, and persistent fever with bacteremia. Am J Surg Pathol 1992; 16(7): 650–657.
76. Bolognia JL, Longley BJ. Genital variant of folliculosebaceous cystic hamartoma. Dermatology 1998; 197(3): 258–260.
77. Nielsen GP, Young RH. Mesenchymal tumors and tumor-like lesions of the female genital tract: a selective review with emphasis on recently described entities. Int J Gynecol Pathol 2001; 20(2): 105–127.
78. Curry JL, Olejnik JL, Wojcik EM. Cellular angiofibroma of the vulva with DNA ploidy analysis. Int J Gynecol Pathol 2001; 20(2): 200–203.
79. Nucci MR, Granter SR, Fletcher CD. Cellular angiofibroma: a benign neoplasm distinct from angiomyofibroblastoma and spindle cell lipoma. Am J Surg Pathol 1997; 21(6): 636–644.
80. Chen E, Fletcher C. Cellular angiofibroma with atypia or sarcomatous transformation: clinicopathologic analysis of 13 cases. Am J Surg Pathol 2010; 34(5): 707–714.
81. Flucke U, van Krieken JH, Mentzel T. Cellular angiofibroma: analysis of 25 cases emphasizing its relationship to spindle cell lipoma and mammary-type myofibroblastoma. Mod Pathol 2011; 24(1): 82–89.
82. Fetsch JF, Laskin WB, Tavassoli FA. Superficial angiomyxoma (cutaneous myxoma): a clinicopathologic study of 17 cases arising in the genital region. Int J Gynecol Pathol 1997; 16(4): 325–334.
83. Calonje E, Guerin D, McCormick D, et al. Superficial angiomyxoma: clinicopathologic analysis of a series of distinctive but poorly recognized cutaneous tumors with tendency for recurrence. Am J Surg Pathol 1999; 23(8): 910–917.
84. Levavi H, Sabah G, Kaplan B, et al. Granular cell tumor of the vulva: six new cases. Arch Gynecol Obstet 2006; 273(4): 246–249.
85. Sturgeon SR, Brinton LA, Devesa SS, et al. In situ and invasive vulvar cancer incidence trends (1973 to 1987). Am J Obstet Gynecol 1992; 166(5): 1482–1485.
86. Conley LJ, Ellerbrock TV, Bush TJ, et al. HIV-1 infection and risk of vulvovaginal and perianal condylomata acuminata and intraepithelial neoplasia: a prospective cohort study. Lancet 2002; 359(9301): 108–113.
87. Daling JR, Sherman KJ, Hislop TG, et al. Cigarette smoking and the risk of anogenital cancer. Am J Epidemiol 1992; 135(2): 180–189.
88. Kurman RJ, Toki T, Schiffman MH. Basaloid and warty carcinomas of the vulva. Distinctive types of squamous cell carcinoma frequently associated with human papillomaviruses. Am J Surg Pathol 1993; 17(2): 133–145.
89. Yang B, Hart WR. Vulvar intraepithelial neoplasia of the simplex (differentiated) type: a clinicopathologic study including analysis of HPV and p53 expression. Am J Surg Pathol 2000; 24(3): 429–441.
90. Shatz P, Bergeron C, Wilkinson EJ, et al. Vulvar intraepithelial neoplasia and skin appendage involvement. Obstet Gynecol 1989; 74(5): 769–774.
91. Preti M, Mezzetti M, Robertson C, et al. Inter-observer variation in histopathological diagnosis and grading of vulvar intraepithelial neoplasia: results of an European collaborative study. Br J Obstet Gynaecol 2000; 107(5): 594–599.
92. Sideri M, Jones RW, Wilkinson EJ, et al. Squamous vulvar intraepithelial neoplasia: 2004 modified terminology, ISSVD Vulvar Oncology Subcommittee. J Reprod Med 2005; 50(11): 807–810.
93. Rosenthal AN, Ryan A, Hopster D, et al. Molecular evidence of a common clonal origin and subsequent divergent clonal evolution in vulval intraepithelial neoplasia, vulval squamous cell carcinoma and lymph node metastases. Int J Cancer 2002; 99(4): 549–554.
94. Esquius J, Brisigotti M, Matias-Guiu X, et al. Keratin expression in normal vulva, non-neoplastic epithelial disorders, vulvar intraepithelial neoplasia, and invasive squamous cell carcinoma. Int J Gynecol Pathol 1991; 10(4): 341–355.
95. Del Pino M, Rodriguez-Carunchio L, Ordi J. Pathways of vulvar intraepithelial neoplasia and squamous cell carcinoma. Histopathology 2013; 62(1): 161–175.
96. Leibowitch M, Neill S, Pelisse M, et al. The epithelial changes associated with squamous cell carcinoma of the vulva: a review of the clinical, histological and viral findings in 78 women. Br J Obstet Gynaecol 1990; 97(12): 1135–1139.
97. Wilkinson EJ, Brown HM. Vulvar Paget disease of urothelial origin: a report of three cases and a proposed classification of vulvar Paget disease. Hum Pathol 2002; 33(5): 549–554.
98. Nauth HF. [Diagnosis of vulvar diseases. 2. Discussion and conclusions for practice]. Fortschr Med 1982; 100(11): 478–481.
99. Funamoto Y, Haba R, Kobayashi TK, et al. Cytologic diagnosis of vulvar Paget’s disease by means of brushing smear: report of a case. Diagn Cytopathol 2010; 38(2): 127–131.
100. De Magnis A, Checcucci V, Catalano C, et al. Vulvar paget disease: a large single-centre experience on clinical presentation, surgical treatment, and long-term outcomes. J Low Gen Tract Dis 2013; 17(2): 104–110.
101. Shaco-Levy R, Bean SM, Vollmer RT, et al. Paget disease of the vulva: a histologic study of 56 cases correlating pathologic features and disease course. Int J Gynecol Pathol 2010; 29(1): 69–78.
102. Fishman DA, Chambers SK, Schwartz PE, et al. Extramammary Paget’s disease of the vulva. Gynecol Oncol 1995; 56(2): 266–270.
103. Sasaki M, Terada T, Nakanuma Y, et al. Anorectal mucinous adenocarcinoma associated with latent perianal Paget’s disease. Am J Gastroenterol 1990; 85(2): 199–202.
104. Nowak MA, Guerriere-Kovach P, Pathan A, et al. Perianal Paget’s disease: distinguishing primary and secondary lesions using immunohistochemical studies including gross cystic disease fluid protein-15 and cytokeratin 20 expression. Arch Pathol Lab Med 1998; 122(12): 1077–1081.
105. Brown HM, Wilkinson EJ. Cytology of secondary vulvar Paget’s disease of urothelial origin: a case report. Acta Cytol 2005; 49(1): 71–74.
106. Brown HM, Wilkinson EJ. Uroplakin-III to distinguish primary vulvar Paget disease from Paget disease secondary to urothelial carcinoma. Hum Pathol 2002; 33(5): 545–548.
107. Hendsch SA, Glover SD, Otis CN, et al. Atypical glandular cells of undetermined significance from extramammary Paget’s of the bladder. Obstet Gynecol 2002; 99(5 Pt 2): 912–914.
108. Snow SN, Desouky S, Lo JS, et al. Failure to detect human papillomavirus DNA in extramammary Paget’s disease. Cancer 1992; 69(1): 249–251.
109. Bacchi CE, Goldfogel GA, Greer BE, et al. Paget’s disease and melanoma of the vulva. Use of a panel of monoclonal antibodies to identify cell type and to microscopically define adequacy of surgical margins. Gynecol Oncol 1992; 46(2): 216–221.
110. Chen YH, Wong TW, Lee JY. Depigmented genital extramammary Paget’s disease: a possible histogenetic link to Toker’s clear cells and clear cell papulosis. J Cutan Pathol 2001; 28(2): 105–108.
111. Brainard JA, Hart WR. Proliferative epidermal lesions associated with anogenital Paget’s disease. Am J Surg Pathol 2000; 24(4): 543–552.
112. Henson D, Tarone R. An epidemiologic study of cancer of the cervix, vagina, and vulva based on the Third National Cancer Survey in the United States. Am J Obstet Gynecol 1977; 129(5): 525–532.
113. Krishnamurthy SC, Sampat MB. Endodermal sinus (yolk sac) tumor of the vulva in a pregnant female. Gynecol Oncol 1981; 11(3): 379–382.
114. Kirschner CV, Yordan EL, De Geest K, et al. Smoking, obesity, and survival in squamous cell carcinoma of the vulva. Gynecol Oncol 1995; 56(1): 79–84.
115. Jones RW, Rowan DM, Kirker J, et al. Vulval lichen planus: progression of pseudoepitheliomatous hyperplasia to invasive vulval carcinomas. Br J Obstet Gynaecol 2001; 108(6): 665–666.
116. Manolitsas T, Biankin S, Jaworski R, et al. Vulval squamous cell carcinoma arising in chronic hidradenitis suppurativa. Gynecol Oncol 1999; 75(2): 285–288.
117. Edge SB, Byrd DR, Compton CC, et al. American Joint Committee on Cancer Staging Manual, 7th edn. New York, NY: Springer; 2010: pp. 379–386.
118. Wilkinson EJ. Superficially invasive carcinoma of the vulva. Clin Obstet Gynecol 1991; 34(3): 651–661.
119. Ambros RA, Malfetano JH, Mihm MC Jr. Clinicopathologic features of vulvar squamous cell carcinomas exhibiting prominent fibromyxoid stromal response. Int J Gynecol Pathol 1996; 15(2): 137–145.
120. Ross MJ, Ehrmann RL. Histologic prognosticators in stage I squamous cell carcinoma of the vulva. Obstet Gynecol 1987; 70(5): 774–784.
121. Drew PA, al-Abbadi MA, Orlando CA, et al. Prognostic factors in carcinoma of the vulva: a clinicopathologic and DNA flow cytometric study. Int J Gynecol Pathol 1996; 15(3): 235–241.
122. Ballouk F, Ambros RA, Malfetano JH, et al. Evaluation of prognostic indicators in squamous carcinoma of the vulva including nuclear DNA content. Mod Pathol 1993; 6(3): 371–375.
123. Husseinzadeh N, Zaino R, Nahhas WA, et al. The significance of histologic findings in predicting nodal metastases in invasive squamous cell carcinoma of the vulva. Gynecol Oncol 1983; 16(1): 105–111.
124. Sedlis A, Homesley H, Bundy BN, et al. Positive groin lymph nodes in superficial squamous cell vulvar cancer. A Gynecologic Oncology Group Study. Am J Obstet Gynecol 1987; 156(5): 1159–1164.
125. Parker RT, Duncan I, Rampone J, et al. Operative management of early invasive epidermoid carcinoma of the vulva. Am J Obstet Gynecol 1975; 123(4): 349–355.
126. Binder SW, Huang I, Fu YS, et al. Risk factors for the development of lymph node metastasis in vulvar squamous cell carcinoma. Gynecol Oncol 1990; 37(1): 9–16.
127. Bjerregaard B, Andreasson B, Visfeldt J, et al. The significance of histology and morphometry in predicting lymph node metastases in patients with squamous cell carcinoma of the vulva. Gynecol Oncol 1993; 50(3): 323–329.
128. Wolber RA, Talerman A, Wilkinson EJ, et al. Vulvar granular cell tumors with pseudocarcinomatous hyperplasia: a comparative analysis with well-differentiated squamous carcinoma. Int J Gynecol Pathol 1991; 10(1): 59–66.
129. Downey GO, Okagaki T, Ostrow RS, et al. Condylomatous carcinoma of the vulva with special reference to human papillomavirus DNA. Obstet Gynecol 1988; 72(1): 68–73.
130. Crum CP. Carcinoma of the vulva: epidemiology and pathogenesis. Obstet Gynecol 1992; 79(3): 448–454.
131. Toki T, Kurman RJ, Park JS, et al. Probable nonpapillomavirus etiology of squamous cell carcinoma of the vulva in older women: a clinicopathologic study using in situ hybridization and polymerase chain reaction. Int J Gynecol Pathol 1991; 10(2): 107–125.
132. Lasser A, Cornog JL, Morris JM. Adenoid squamous cell carcinoma of the vulva. Cancer 1974; 33(1): 224–227.
133. Underwood JW, Adcock LL, Okagaki T. Adenosquamous carcinoma of skin appendages (adenoid squamous cell carcinoma, pseudoglandular squamous cell carcinoma, adenocanthoma of sweat gland of Lever) of the vulva: a clinical and ultrastructural study. Cancer 1978; 42(4): 1851–1858.
134. Wilkinson EJ, Croker BP, Friedrich EG Jr, et al. Two distinct pathologic types of giant cell tumor of the vulva. A report of two cases. J Reprod Med 1988; 33(6): 519–522.
135. Carr KA, Bulengo-Ransby SM, Weiss LM, et al. Lymphoepitheliomalike carcinoma of the skin. A case report with immunophenotypic analysis and in situ hybridization for Epstein–Barr viral genome. Am J Surg Pathol 1992; 16(9): 909–913.
136. Santeusanio G, Schiaroli S, Anemona L, et al. Carcinoma of the vulva with sarcomatoid features: a case report with immunohistochemical study. Gynecol Oncol 1991; 40(2): 160–163.
137. Steeper TA, Piscioli F, Rosai J. Squamous cell carcinoma with sarcoma-like stroma of the female genital tract. Clinicopathologic study of four cases. Cancer 1983; 52(5): 890–898.
138. Escalonilla P, Grilli R, Canamero M, et al. Sebaceous carcinoma of the vulva. Am J Dermatopathol 1999; 21(5): 468–472.
139. Jacobs DM, Sandles LG, Leboit PE. Sebaceous carcinoma arising from Bowen’s disease of the vulva. Arch Dermatol 1986; 122(10): 1191–1193.
140. Curtin JP, Saigo P, Slucher B, et al. Soft-tissue sarcoma of the vagina and vulva: a clinicopathologic study. Obstet Gynecol 1995; 86(2): 269–272.
141. De Hullu JA, Hollema H, Piers DA, et al. Sentinel lymph node procedure is highly accurate in squamous cell carcinoma of the vulva. J Clin Oncol 2000; 18(15): 2811–2816.
142. Kraus FT, Perezmesa C. Verrucous carcinoma. Clinical and pathologic study of 105 cases involving oral cavity, larynx and genitalia. Cancer 1966; 19(1): 26–38.
143. Lucas WE, Benirschke K, Lebherz TB. Verrucous carcinoma of the female genital tract. Am J Obstet Gynecol 1974; 119(4): 435–440.
144. Boutas I, Sofoudis C, Kalampokas E, et al. Verrucous carcinoma of the vulva: a case report. Case Rep Obstet Gynecol 2013; 2013: 932712.
145. Dinh TV, Powell LC Jr, Hannigan EV, et al. Simultaneously occurring condylomata acuminata, carcinoma in situ and verrucous carcinoma of the vulva and carcinoma in situ of the cervix in a young woman. A case report. J Reprod Med 1988; 33(6): 510–513.
146. Gualco M, Bonin S, Foglia G, et al. Morphologic and biologic studies on ten cases of verrucous carcinoma of the vulva supporting the theory of a discrete clinico-pathologic entity. Int J Gynecol Cancer 2003; 13(3): 317–324.
147. Mulayim N, Foster Silver D, Tolgay Ocal I, et al. Vulvar basal cell carcinoma: two unusual presentations and review of the literature. Gynecol Oncol 2002; 85(3): 532–537.
148. Mulvany NJ, Rayoo M, Allen DG. Basal cell carcinoma of the vulva: a case series. Pathology 2012; 44(6): 528–533.
149. Merino MJ, LiVolsi VA, Schwartz PE, et al. Adenoid basal cell carcinoma of the vulva. Int J Gynecol Pathol 1982; 1(3): 299–306.
150. Feakins RM, Lowe DG. Basal cell carcinoma of the vulva: a clinicopathologic study of 45 cases. Int J Gynecol Pathol 1997; 16(4): 319–324.
151. Piura B, Rabinovich A. [Basal cell carcinoma of the vulva]. Harefuah 1999; 137(1–2): 70–72.
152. Benedet JL, Miller DM, Ehlen TG, et al. Basal cell carcinoma of the vulva: clinical features and treatment results in 28 patients. Obstet Gynecol 1997; 90(5): 765–768.
153. Bing Z, Pasha T, Wang LP, et al. Malignant mixed mullerian tumor: an immunohistochemical study. Patholog Res Int 2012; 2012: 569609.
154. Chen KT. Merkel’s cell (neuroendocrine) carcinoma of the vulva. Cancer 1994; 73(8): 2186–2191.
155. Feng H, Shuda M, Chang Y, et al. Clonal integration of a polyomavirus in human Merkel cell carcinoma. Science (New York, NY) 2008; 319(5866): 1096–100.
156. Duncavage EJ, Le B-M, Wang D, et al. Merkel cell polyomavirus: a specific marker for Merkel cell carcinoma in histologically similar tumors. Am J Surg Pathol 2009; 33(12): 1771–1777.
157. Cardosi RJ, Speights A, Fiorica JV, et al. Bartholin’s gland carcinoma: a 15-year experience. Gynecol Oncol 2001; 82(2): 247–251.
158. Woida FM, Ribeiro-Silva A. Adenoid cystic carcinoma of the Bartholin gland: an overview. Arch Pathol Lab Med 2007; 131(5): 796–798.
159. Padmanabhan V, Cooper K. Concomitant adenoma and hybrid carcinoma of salivary gland type arising in Bartholin’s gland. Int J Gynecol Pathol 2000; 19(4): 377–380.
160. Sheard JD, Vijayanand R, Herrington CS, et al. High-grade squamous intraepithelial neoplasia in a Bartholin’s gland cyst associated with HPV 16 infection. Histopathology 2000; 37(1): 87–88.
161. Chamlian DL, Taylor HB. Primary carcinoma of Bartholin’s gland. A report of 24 patients. Obstet Gynecol 1972; 39(4): 489–494.
162. Wheelock JB, Goplerud DR, Dunn LJ, et al. Primary carcinoma of the Bartholin gland: a report of ten cases. Obstet Gynecol 1984; 63(6): 820–824.
163. Jour G, Paniz Mondolfi AE, Slova D, et al. Anogenital sweat gland adenocarcinoma of the vulva: a diagnostic conundrum. Am J Dermatopathol 2012; 34(7): 773–777.
164. Wick MR, Goellner JR, Wolfe JT III, et al. Vulvar sweat gland carcinomas. Arch Pathol Lab Med 1985; 109(1): 43–47.
165. Graf AH, Su HC, Tubbs RR, et al. Primary neuroendocrine differentiated mucinous adenocarcinoma of the vulva: case report and review of the literature. Anticancer Res 1998; 18(3B): 2041–2045.
166. Van der Putte SC, Van Gorp LH. Adenocarcinoma of the mammary-like glands of the vulva: a concept unifying sweat gland carcinoma of the vulva, carcinoma of supernumerary mammary glands and extramammary Paget’s disease. J Cutan Pathol 1994; 21(2): 157–163.
167. Taylor RN, Lacey CG, Shuman MA. Adenocarcinoma of Skene’s duct associated with a systemic coagulopathy. Gynecol Oncol 1985; 22(2): 250–256.
168. Egan CA, Bradley RR, Logsdon VK, et al. Vulvar melanoma in childhood. Arch Dermatol 1997; 133(3): 345–348.
169. Hassanein AM, Mrstik ME, Hardt NS, et al. Malignant melanoma associated with lichen sclerosus in the vulva of a 10-year-old. Pediatr Dermatol 2004; 21(4): 473–476.
170. Friedman RJ, Kopf AW, Jones WB. Malignant melanoma in association with lichen sclerosus on the vulva of a 14-year-old. Am J Dermatopathol 1984; 6(Suppl): 253–256.
171. Verschraegen CF, Benjapibal M, Supakarapongkul W, et al. Vulvar melanoma at the M. D. Anderson Cancer Center: 25 years later. Int J Gynecol Cancer 2001; 11(5): 359–364.
172. Sugiyama VE, Chan JK, Shin JY, et al. Vulvar melanoma: a multivariable analysis of 644 patients. Obstet Gynecol 2007; 110(2 Pt 1): 296–301.
173. Tcheung WJ, Selim MA, Herndon JE, et al. Clinicopathologic study of 85 cases of melanoma of the female genitalia. J Am Acad Dermatol 2012; 67(4): 598–605.
174. Mihm MC Jr, Clark WH Jr, From L. The clinical diagnosis, classification and histogenetic concepts of the early stages of cutaneous malignant melanomas. N Engl J Med 1971; 284(19): 1078–1082.
175. Breslow A. Tumor thickness, level of invasion and node dissection in stage I cutaneous melanoma. Ann Surg 1975; 182(5): 572–575.
176. Dunton CJ, Kautzky M, Hanau C. Malignant melanoma of the vulva: a review. Obstet Gynecol Surv 1995; 50(10): 739–746.
177. Chung AF, Woodruff JM, Lewis JL Jr. Malignant melanoma of the vulva: a report of 44 cases. Obstet Gynecol 1975; 45(6): 638–646.
178. Johnson TL, Kumar NB, White CD, et al. Prognostic features of vulvar melanoma: a clinicopathologic analysis. Int J Gynecol Pathol 1986; 5(2): 110–118.
179. Podratz KC, Gaffey TA, Symmonds RE, et al. Melanoma of the vulva: an update. Gynecol Oncol 1983; 16(2): 153–168.
180. Omholt K, Grafström E, Kanter-Lewensohn L, et al. KIT pathway alterations in mucosal melanomas of the vulva and other sites. Clin Cancer Res 2011; 17(12): 3933–3942.
181. Losch A, Joura EA, Stani J, et al. Leiomyosarcoma of the vulva. A case report. J Reprod Med 2001; 46(6): 609–612.
182. Hensley GT, Friedrich EG Jr. Malignant fibroxanthoma: a sarcoma of the vulva. Am J Obstet Gynecol 1973; 116(2): 289–291.
183. Taylor RN, Bottles K, Miller TR, et al. Malignant fibrous histiocytoma of the vulva. Obstet Gynecol 1985; 66(1): 145–148.
184. Nirenberg A, Ostör AG, Slavin J, et al. Primary vulvar sarcomas. Int J Gynecol Pathol 1995; 14(1): 55–62.
185. Edelweiss M, Malpica A. Dermatofibrosarcoma protuberans of the vulva: a clinicopathologic and immunohistochemical study of 13 cases. Am J Surg Pathol 2010; 34(3): 393–400.
186. Bock JE, Andreasson B, Thorn A, et al. Dermatofibrosarcoma protuberans of the vulva. Gynecol Oncol 1985; 20(1): 129–135.
187. Kholova I, Ryska A, Dedic K. Composite tumor consisting of dermatofibrosarcoma protuberans and giant cell fibroblastoma associated with intratumoral endometriosis. Report of a case. Pathol Res Pract 2001; 197(4): 263–270.
188. Vanni R, Faa G, Dettori T, et al. A case of dermatofibrosarcoma protuberans of the vulva with a COL1A1/PDGFB fusion identical to a case of giant cell fibroblastoma. Virchows Arch 2000; 437(1): 95–100.
189. Gökden N, Dehner LP, Zhu X, et al. Dermatofibrosarcoma protuberans of the vulva and groin: detection of COL1A1–PDGFB fusion transcripts by RT-PCR. J Cutan Pathol 2003; 30(3): 190–195.
190. Copeland LJ, Sneige N, Stringer CA, et al. Alveolar rhabdomyosarcoma of the female genitalia. Cancer 1985; 56(4): 849–855.
191. Corson JM, Pinkus GS. Intracellular myoglobin – a specific marker for skeletal muscle differentiation in soft tissue sarcomas. An immunoperoxidase study. Am J Pathol 1981; 103(3): 384–389.
192. Begin LR, Clement PB, Kirk ME, et al. Aggressive angiomyxoma of pelvic soft parts: a clinicopathologic study of nine cases. Hum Pathol 1985; 16(6): 621–628.
193. Cheung TH, Chan MK, Chang A. Aggressive angiomyxoma of the female perineum: case reports. Aust NZ J Obstet Gynaecol 1991; 31(3): 285–287.
194. Fetsch JF, Laskin WB, Lefkowitz M, et al. Aggressive angiomyxoma: a clinicopathologic study of 29 female patients. Cancer 1996; 78(1): 79–90.
195. Granter SR, Nucci MR, Fletcher CD. Aggressive angiomyxoma: reappraisal of its relationship to angiomyofibroblastoma in a series of 16 cases. Histopathology 1997; 30(1): 3–10.
196. Nucci MR, Weremowicz S, Neskey DM, et al. Chromosomal translocation t(8;12) induces aberrant HMGIC expression in aggressive angiomyxoma of the vulva. Genes Chromosomes Cancer 2001; 32(2): 172–176.
197. Sutton BJ, Laudadio J. Aggressive angiomyxoma. Arch Pathol Lab Med 2012; 136(2): 217–221.
198. Dreux N, Marty M, Chibon F, et al. Value and limitation of immunohistochemical expression of HMGA2 in mesenchymal tumors: about a series of 1052 cases. Mod Pathol 2010; 23(12): 1657–1666.
199. Steeper TA, Rosai J. Aggressive angiomyxoma of the female pelvis and perineum. Report of nine cases of a distinctive type of gynecologic soft-tissue neoplasm. Am J Surg Pathol 1983; 7(5): 463–475.
200. Guillou L, Wadden C, Coindre JM, et al. “Proximal-type” epithelioid sarcoma, a distinctive aggressive neoplasm showing rhabdoid features. Clinicopathologic, immunohistochemical, and ultrastructural study of a series. Am J Surg Pathol 1997; 21(2): 130–146.
201. Kim H-J, Kim M-H, Kwon J, et al. Proximal-type epithelioid sarcoma of the vulva with INI1 diagnostic utility. Ann Diagn Pathol 2012; 16(5): 411–415.
202. Ong AC, Lim TYK, Tan TC, et al. Proximal epithelioid sarcoma of the vulva: a case report and review of current medical literature. J Obstet Gynaecol Res 2012; 38(7): 1032–1035.
203. Hollmann TJ, Hornick JL. INI1-deficient tumors: diagnostic features and molecular genetics. Am J Surg Pathol 2011; 35(10): e47–63.
204. Bolis GB, Maccio T. Clear cell adenocarcinoma of the vulva arising in endometriosis. A case report. Eur J Gynaecol Oncol 2000; 21(4): 416–417.
205. Irvin W, Pelkey T, Rice L, et al. Endometrial stromal sarcoma of the vulva arising in extraovarian endometriosis: a case report and literature review. Gynecol Oncol 1998; 71(2): 313–316.
206. Plouffe L Jr, Tulandi T, Rosenberg A, et al. Non-Hodgkin’s lymphoma in Bartholin’s gland: case report and review of literature. Am J Obstet Gynecol 1984; 148(5): 608–609.
207. Jiang W, Li L, He Y-M, et al. Langerhans cell histiocytosis of the female genital tract: a literature review with additional three case studies in China. Arch Gynecol Obstet 2012; 285(1): 99–103.
208. Lieberman PH, Jones CR, Steinman RM, et al. Langerhans cell (eosinophilic) granulomatosis. A clinicopathologic study encompassing 50 years. Am J Surg Pathol 1996; 20(5): 519–552.
209. Basgul A, Gokaslan H, Kavak ZN, et al. Primary yolk sac tumor (endodermal sinus tumor) of the vulva: case report and review of the literature. Eur J Gynaecol Oncol 2006; 27(4): 395–398.
210. Weber AM, Walters MD, Schover LR, et al. Vaginal anatomy and sexual function. Obstet Gynecol 1995; 86(6): 946–949.
211. Elliott GB, Elliott JD. Superficial stromal reactions of lower genital tract. Arch Pathol 1973; 95(2): 100–101.
212. Powell DM, Newman KD, Randolph J. A proposed classification of vaginal anomalies and their surgical correction. J Pediatr Surg 1995; 30(2): 271–276.
213. Fliegner JR. Congenital atresia of the vagina. Surg Gynecol Obstet 1987; 165(5): 387–391.
214. Wisniewski PM, Wilkinson EJ. Postpartum vaginal atrophy. Am J Obstet Gynecol 1991; 165(4 Pt 2): 1249–1254.
215. Batta K, Munday PE, Tatnall FM. Pemphigus vulgaris localized to the vagina presenting as chronic vaginal discharge. Br J Dermatol 1999; 140(5): 945–947.
216. Sobel JD. Vulvovaginitis in healthy women. Compr Ther 1999; 25(6–7): 335–346.
217. Nogales-Ortiz F, Tarancon I, Nogales FF Jr. The pathology of female genital tuberculosis. A 31-year study of 1436 cases. Obstet Gynecol 1979; 53(4): 422–428.
218. Mondal SK. Histopathologic analysis of female genital tuberculosis: a fifteen-year retrospective study of 110 cases in eastern India. Türk patoloji dergisi 2013; 29(1): 41–45.
219. Curtis EM, Pine L. Actinomyces in the vaginas of women with and without intrauterine contraceptive devices. Am J Obstet Gynecol 1981; 140(8): 880–884.
220. Othman NH, Ismail AN. Endometrial amoebiasis. Eur J Obstet Gynecol Reprod Biol 1993; 52(2): 135–137.
221. Leclair CM, Hart AE, Goetsch MF, et al. Group B Streptococcus: prevalence in a non-obstetric population. J Low Genital Tract Dis 2010; 14(3): 162–166.
222. Friedrich EG Jr, Siegesmund KA. Tampon-associated vaginal ulcerations. Obstet Gynecol 1980; 55(2): 149–156.
223. Wick MR, Brown BA, Young RH, et al. Spindle-cell proliferations of the urinary tract. An immunohistochemical study. Am J Surg Pathol 1988; 12(5): 379–389.
224. Skelton H, Smith KJ. Spindle cell epithelioma of the vagina shows immunohistochemical staining supporting its origin from a primitive/progenitor cell population. Arch Pathol Lab Med 2001; 125(4): 547–550.
225. Saad AJ, Donovan TM, Truong LD. Malakoplakia of the vagina diagnosed by fine-needle aspiration cytology. Diagn Cytopathol 1993; 9(5): 559–561.
226. Rollason TP, Byrne P, Williams A. Immunohistochemical and electron microscopic findings in benign fibroepithelial vaginal polyps. J Clin Pathol 1990; 43(3): 224–229.
227. Song JS, Song DE, Kim K-R, et al. Cellular pseudosarcomatous fibroepithelial stromal polyp of the vagina during pregnancy: a lesion that is overdiagnosed as a malignant tumor. Korean J Pathol 2012; 46(5): 494–498.
228. Mucitelli DR, Charles EZ, Kraus FT. Vulvovaginal polyps. Histologic appearance, ultrastructure, immunocytochemical characteristics, and clinicopathologic correlations. Int J Gynecol Pathol 1990; 9(1): 20–40.
229. Hartmann CA, Sperling M, Stein H. So-called fibroepithelial polyps of the vagina exhibiting an unusual but uniform antigen profile characterized by expression of desmin and steroid hormone receptors but no muscle-specific actin or macrophage markers. Am J Clin Pathol 1990; 93(5): 604–608.
230. Nucci MR, Young RH, Fletcher CD. Cellular pseudosarcomatous fibroepithelial stromal polyps of the lower female genital tract: an underrecognized lesion often misdiagnosed as sarcoma. Am J Surg Pathol 2000; 24(2): 231–240.
231. Laskin WB, Fetsch JF, Tavassoli FA. Superficial cervicovaginal myofibroblastoma: fourteen cases of a distinctive mesenchymal tumor arising from the specialized subepithelial stroma of the lower female genital tract. Hum Pathol 2001; 32(7): 715–725.
232. Cohen M, Pedemonte L, Drut R. Pigmented mullerian papilloma of the vagina. Histopathology 2001; 39(5): 541–543.
233. Hampton HL, Huffman HT, Meeks GR. Extraovarian Brenner tumor. Obstet Gynecol 1992; 79(5 (Pt 2)): 844–846.
234. Branton PA, Tavassoli FA. Spindle cell epithelioma, the so-called mixed tumor of the vagina. A clinicopathologic, immunohistochemical, and ultrastructural analysis of 28 cases. Am J Surg Pathol 1993; 17(5): 509–515.
235. Peña-Fernández M, Abdulkader-Nallib I, Novo-Domínguez A, et al. Vaginal tubulovillous adenoma: a clinicopathologic and molecular study with review of the literature. Int J Gynecol Pathol 2013; 32(1): 131–136.
236. Kurman RJ, Prabha AC. Thyroid and parathyroid glands in the vaginal wall: report of a case. Am J Clin Pathol 1973; 59(4): 503–507.
237. Patrelli TS, Franchi L, Gizzo S, et al. [Rhabdomyoma of the vagina. Case report and short literature review]. Ann Pathol 2012; 32(1): 53–57.
238. Imai A, Furui T, Hatano Y, et al. Leiomyoma and rhabdomyoma of the vagina. Vaginal myoma. J Obstet Gynaecol 2008; 28(6): 563–566.
239. Chen KT. Angiomyolipoma of the vagina. Gynecol Oncol 1990; 37(2): 302–304.
240. Celik F, Arioz DT, Koken GN, et al. Very rare cause of vaginal mass in pregnancy: cavernous hemangioma. J Obstet Gynaecol Res. 2012; 38(5): 889–891.
241. Gomez-Laencina AM, Martinez Diaz F, Izquierdo Sanjuanes B, et al. Localized neurofibromatosis of the female genital system: a case report and review of the literature. J Obstet Gynaecol Res 2012; 38(6): 953–956.
242. Akl MN, Naidu SG, McCullough AE, et al. Vaginal paraganglioma presenting as a pelvic mass. Surgery 2010; 147(1): 169–171.
243. Azzopardi JG, Eusebi V, Tison V, et al. Neurofibroma with rhabdomyomatous differentiation: benign “Triton” tumour of the vagina. Histopathology 1983; 7(4): 561–572.
244. Moldavsky M, Stayerman C, Turani H. Vaginal glomus tumor presented as a painless cystic mass. Gynecol Oncol 1998; 69(2): 172–174.
245. Fitzhugh VA, Houck K, Heller DS. Vaginal blue nevus: report of a case and review of the literature. J Low Genital Tract Dis 2011; 15(4): 325–327.
246. Janco JMT, Markovic SN, Weaver AL, et al. Vulvar and vaginal melanoma: case series and review of current management options including neoadjuvant chemotherapy. Gynecol Oncol 2013; 129: 533–537.
247. Bottles K, Lacey CG, Miller TR. Atypical melanocytic hyperplasia of the vagina. Gynecol Oncol 1984; 19(2): 226–230.
248. Laronda MM, Unno K, Butler LM, et al. The development of cervical and vaginal adenosis as a result of diethylstilbestrol exposure in utero. Differentiation 2012; 84(3): 252–260.
249. Dungar CF, Wilkinson EJ. Vaginal columnar cell metaplasia. An acquired adenosis associated with topical 5-fluorouracil therapy. J Reprod Med 1995; 40(5): 361–366.
250. Sedlacek T V, Riva JM, Magen AB, et al. Vaginal and vulvar adenosis. An unsuspected side effect of CO2 laser vaporization. J Reprod Med 1990; 35(11): 995–1001.
251. Sharp GB, Cole P, Anderson D, et al. Clear cell adenocarcinoma of the lower genital tract. Correlation of mother’s recall of diethylstilbestrol history with obstetrical records. Cancer 1990; 66(10): 2215–2220.
252. Watanabe Y, Ueda H, Nozaki K, et al. Advanced primary clear cell carcinoma of the vagina not associated with diethylstilbestrol. Acta Cytol 2002; 46(3): 577–581.
253. Fowler WC Jr, Schmidt G, Edelman DA, et al. Risks of cervical intraepithelial neoplasia among DES-exposed women. Obstet Gynecol 1981; 58(6): 720–724.
254. Mattingly RF, Stafl A. Cancer risk in diethylstilbestrol-exposed offspring. Am J Obstet Gynecol 1976; 126(5): 543–548.
255. Robboy SJ, Keh PC, Nickerson RJ, et al. Squamous cell dysplasia and carcinoma in situ of the cervix and vagina after prenatal exposure to diethylstilbestrol. Obstet Gynecol 1978; 51(5): 528–535.
256. Robboy SJ, Noller KL, O’Brien P, et al. Increased incidence of cervical and vaginal dysplasia in 3,980 diethylstilbestrol-exposed young women. Experience of the National Collaborative Diethylstilbestrol Adenosis Project. JAMA 1984; 252(21): 2979–2983.
257. Antonioli DA, Rosen S, Burke L, et al. Glandular dysplasia in diethylstilbestrol-associated vaginal adenosis. A case report and review of the literature. Am J Clin Pathol 1979; 71(6): 715–721.
258. Hart WR, Townsend DE, Aldrich JO, et al. Histopathologic spectrum of vaginal adenosis and related changes in stilbestrol-exposed females. Cancer 1976; 37(2): 763–775.
259. Antonioli DA, Burke L. Vaginal adenosis. Analysis of 325 biopsy specimens from 100 patients. Am J Clin Pathol 1975; 64(5): 625–638.
260. Robboy SJ, Kaufman RH, Prat J, et al. Pathologic findings in young women enrolled in the National Cooperative Diethylstilbestrol Adenosis (DESAD) project. Obstet Gynecol 1979; 53(3): 309–317.
261. Robboy SJ, Young RH, Welch WR, et al. Atypical vaginal adenosis and cervical ectropion. Association with clear cell adenocarcinoma in diethylstilbestrol-exposed offspring. Cancer 1984; 54(5): 869–875.
262. Benedet JL, Sanders BH. Carcinoma in situ of the vagina. Am J Obstet Gynecol 1984; 148(5): 695–700.
263. Lenehan PM, Meffe F, Lickrish GM. Vaginal intraepithelial neoplasia: biologic aspects and management. Obstet Gynecol 1986; 68(3): 333–337.
264. Daw E. Primary carcinoma of the vagina. J Obstet Gynaecol Br Commonw 1971; 78(9): 853–856.
265. Stafl A, Mattingly RF. Vaginal adenosis: a precancerous lesion? Am J Obstet Gynecol 1974; 120(5): 666–677.
266. McCluggage WG. Premalignant lesions of the lower female genital tract: cervix, vagina and vulva. Pathology 2013; 45(3): 214–228.
267. Brinton LA, Nasca PC, Mallin K, et al. Case-control study of in situ and invasive carcinoma of the vagina. Gynecol Oncol 1990; 38(1): 49–54.
268. McCluggage WG. Lymphoepithelioma-like carcinoma of the vagina. J Clin Pathol 2001; 54(12): 964–965.
269. Joseph RE, Enghardt MH, Doering DL, et al. Small cell neuroendocrine carcinoma of the vagina. Cancer 1992; 70(4): 784–789.
270. Prasad CJ, Ray JA, Kessler S. Primary small cell carcinoma of the vagina arising in a background of atypical adenosis. Cancer 1992; 70(10): 2484–2487.
271. Eichhorn JH, Young RH. Neuroendocrine tumors of the genital tract. Am J Clin Pathol 2001; 115(Suppl): S94–112.
272. Bhalodia JN, Kapapura DV, Parekh MN. Primary small cell neuroendocrine carcinoma of vagina: a rare case report. Pathol Res Int 2011; 2011: 306921.
273. Rose PG, Stoler MH, Abdul-Karim FW. Papillary squamotransitional cell carcinoma of the vagina. Int J Gynecol Pathol 1998; 17(4): 372–375.
274. McCluggage WG, Price JH, Dobbs SP. Primary adenocarcinoma of the vagina arising in endocervicosis. Int J Gynecol Pathol 2001; 20(4): 399–402.
275. Vang R, Whitaker BP, Farhood AI, et al. Immunohistochemical analysis of clear cell carcinoma of the gynecologic tract. Int J Gynecol Pathol 2001; 20(3): 252–259.
276. Tewari DS, McHale MT, Kuo JV, et al. Primary invasive vaginal cancer in the setting of the Mayer–Rokitansky–Kuster–Hauser syndrome. Gynecol Oncol 2002; 85(2): 384–387.
277. DeMars LR, Van Le L, Huang I, et al. Primary non-clear-cell adenocarcinomas of the vagina in older DES-exposed women. Gynecol Oncol 1995; 58(3): 389–392.
278. Nagar HA, McKinney KA, Price JH, et al. Enteric epithelium progressing through dysplasia to adenocarcinoma within the vagina. Eur J Surg Oncol 1999; 25(1): 106–107.
279. Herbst AL, Robboy SJ, Scully RE, et al. Clear-cell adenocarcinoma of the vagina and cervix in girls: analysis of 170 registry cases. Am J Obstet Gynecol 1974; 119(5): 713–724.
280. Ragnarsson-Olding B, Johansson H, Rutqvist LE, et al. Malignant melanoma of the vulva and vagina. Trends in incidence, age distribution, and long-term survival among 245 consecutive cases in Sweden 1960–1984. Cancer 1993; 71(5): 1893–1897.
281. Neven P, Shepherd JH, Masotina A, et al. Malignant melanoma of the vulva and vagina: a report of 23 cases presenting in a 10-year period. Int J Gynecol Cancer 1994; 4(6): 379–383.
282. Piura B, Rabinovich A, Yanai-Inbar I. Primary malignant melanoma of the vagina: case report and review of literature. Eur J Gynaecol Oncol 2002; 23(3): 195–198.
283. Heller DS, Moomjy M, Koulos J, et al. Vulvar and vaginal melanoma. A clinicopathologic study. J Reprod Med 1994; 39(12): 945–948.
284. Chung AF, Casey MJ, Flannery JT, et al. Malignant melanoma of the vagina – report of 19 cases. Obstet Gynecol 1980; 55(6): 720–727.
285. Li RF, Gupta M, McCluggage WG, et al. Embryonal rhabdomyosarcoma (botryoid type) of the uterine corpus and cervix in adult women: report of a case series and review of the literature. Am J Surg Pathol 2013; 37(3): 344–355.
286. Hemida R, Goda H, Abdel-Hady E-S, et al. Embryonal rhabdomyosarcoma of the female genital tract: 5 years’ experience. J Exp Therap Oncol 2012; 10(2): 135–137.
287. Raney RB, Maurer HM, Anderson JR, et al. The Intergroup Rhabdomyosarcoma Study Group (IRSG): major lessons From the IRS-I through IRS-IV studies as background for the current IRS-V treatment protocols. Sarcoma 2001; 5(1): 9–15.
288. Eusebi V, Ceccarelli C, Gorza L, et al. Immunocytochemistry of rhabdomyosarcoma. The use of four different markers. Am J Surg Pathol 1986; 10(4): 293–299.
289. Mandong BM, Ngbea JA. Childhood rhabdomyosarcoma: a review of 35 cases and literature. Niger J Med 2011; 20(4): 466–469.
290. Takehara M, Hayakawa O, Itoh E, et al. A case of a malignant mixed tumor in the vagina. J Obstet Gynaecol Res 1998; 24(1): 7–11.
291. Gangopadhyay M, Raha K, Sinha SK, et al. Endodermal sinus tumor of the vagina in children: a report of two cases. Indian J Pathol Microbiol 2009; 52(3): 403–404.
292. Harris NL, Scully RE. Malignant lymphoma and granulocytic sarcoma of the uterus and vagina. A clinicopathologic analysis of 27 cases. Cancer 1984; 53(11): 2530–2545.
293. Guastafierro S, Tedeschi A, Criscuolo C, et al. Primary extranodal non-Hodgkin’s lymphoma of the vagina: a case report and a review of the literature. Acta Haematol 2012; 128(1): 33–38.